NRX Pharmaceuticals

NAQ:NRXP · US6294442099

PharmaceuticalsX-Small

360° View

Value100

Price/Sales59

Price/Earnings95

Price/Book91

Dividend Yield1

Growth59

Revenue Growth100

Profit Growth64

Capital Growth1

TSR 52w61

Safety4

Leverage30

Liquidity21

Refinancing4

Combined53

Sentiment47

Analyst Opinions100

Pro Holdings9

Opinion Changes50

Market Pulse39

Profile

CountryUSA

IndustryPharmaceuticals

SizeX-Small

TypePublic Company

ExchangeNASDAQCM

Employees13

Websitenrxpharma.com

ISINUS6294442099

Last UpdateApr 2, 2026

Index & Theme

Pain ManagementNeurologyChronic DiseasesAddictionPsychiatryDigital Mental HealthNeurosciencePsychedelic-Based TherapyCentral Nervous SystemBiotechnologyPharmaceutical

Description

NRx Pharmaceuticals, Inc. operates as a clinical-stage bio-pharmaceutical company. The company develops and will distribute, through its wholly-owned operating subsidiaries, NeuroRx, Inc., (NeuroRx), novel therapeutics for the treatment of central ne…

Analysis

NRX Pharmaceuticals's 360° View rank of 49 places it below its peer average — better than 49% of its true peers.

It's growing solidly (59) and looks cheap versus peers (100). On safety it is highly leveraged (4), and the market shows muted sentiment (47). Taken together, its Combined rank of 53 reads as above its peer average.

360° rank · history

1007550250

2026

All-time high

Mar 2026

All-time low

Jun 2026

Average rank

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023

Price/Sales

—

Price/Earnings

—

Price/Book

—

Dividend Yield

—

Value (overall)

100

—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare NRX Pharmaceuticals with its peers

Relmada Therapeutics

NAQ:RLMD

—

CountryUSA

IndustryPharmaceuticals

SizeSmall

Full Stock Analysis →

MIRA Pharmaceuticals

NAQ:MIRA

—

CountryUSA

IndustryPharmaceuticals

SizeX-Small

Full Stock Analysis →

LB Pharmaceuticals

NMQ:LBRX

CountryUSA

IndustryPharmaceuticals

SizeSmall

Full Stock Analysis →

Rapport Therapeutics

NMQ:RAPP

CountryUSA

IndustryPharmaceuticals

SizeSmall

Full Stock Analysis →

CalciMedica

NAQ:CALC

—

CountryUSA

IndustryPharmaceuticals

SizeX-Small

Full Stock Analysis →

EyePoint

NMQ:EYPT

CountryUSA

IndustryPharmaceuticals

SizeSmall

Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View

1 · Watch OutGood· 100

Value

1 · ExpensiveGood Value· 100

Quality

1 · Weak FundamentalsHigh Quality· 100

Growth

1 · Tough TimesHigh Growth· 100

Safety

1 · High LeverageWell-Financed· 100

Sentiment

1 · SkepticismPositive· 100

Learn More →